DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20170664

Clinical and histological spectrum of hepatitis C disease associated with persistently normal alanine aminotransferase levels

Maleha Asim, Sadaf Jafar, Aashi Mughal, quratulain zia, hamid ali, aneela jamil, Ghazal Zaffar

Abstract


Background: Around 20% of patients with chronic hepatitis C infection (HCV) have persistently normal alanine aminotransferase (PNALT) levels. These patients are considered to have mild degree of histological hepatic damage. This study was conducted to compare the histological degree of necro-inflammation and stage of fibrosis among HCV patients with PNALT and patients with persistently or intermittently elevated serum ALT (PIEALT) levels..

Methods: This study includes 154 untreated patients with serological and histological diagnosis of chronic HCV infection. A total of 70 patients with PNALT (group A) and 84 patients with PIEALT (group B) were identified and treated with 6 months interferon therapy. Histological grade of necro-inflammatory activity and the stage of fibrosis was evaluated by Ishak scoring system. HCV-RNA quantification was done by real-time polymerase chain reaction (PCR). Further univariate and multivariate analysis was done to evaluate correlation between patients characteristics and significant hepatic fibrosis..

Results: Out of one hundred and fifty four patients, mean ALT was 30.59 ± 5.59 U/L in group A as compare to 68.65 ± 23.17 U/L in group B (p = 0.001). Patients with PNALT were younger (p = 0.005) with milder grade of necrosis (p = 0.037), lower serum HCV viral load (p = 0.044) and significant achievement of sustained virological response (p = 0.012) as compare to patients with abnormal ALT. Different variable were also analysed by univariate and mutivaraite analysis among patients with significant and insignificant fibrosis. High serum HCV-RNA level was found to be the independent variable predictive of advanced fibrosis among HCV infected patients (OR = 0.89; 95% CI = 1.65-1.94; p < 0.001) with r2 = 80%.

Conclusions: Our study suggests that normal serum ALT does not mean healthy liver. So, histological evaluation is still an essential tool to assess liver damage precisely.

Keywords


HCV-RNA, Liver biopsy, PNALT, PIEALT, SVR

Full Text:

PDF

References


Nadeem A, Hussain MM, Aslam M. Co rrelation of serum alanine aminotransferase and aspartate aminotransferase levels to liver histology in chronic hepatitis C. J Coll Physicians Surg Pak. 2010;20(10):657-61.

Dayem WAAE, Emam M, Shaheen NE, Emara MH, Darweish EM, Abdelwahab NA. Can Combinations of Non-Invasive Parameters Replace Liver Biopsy in the Diagnosis of Hepatic Fibrosis in Egyptian Patients with Chronic Hepatitis C. British Microbiology Research J. 2013;3(3):259-71.

Bhatty SA, Shaikh NA, Akhter SS. Liver histology in hepatitis C virus positive patients with normal and elevated alanine amino transferase levels. J Pak Med Assoc. 2009;59:832-4.

Liu P, Li Y, Sun C-m. Correlations of serum hepatitis C virus RNA and alanine transaminase with liver histopathological changes in patients with chronic hepatitis C. Laboratory Medicine. 2009;40(3):167-9.

Zechini B, Pasquazzi C, Aceti A. Correlation of serum aminotransferases with HCV RNA levels and histological findings in patients with chronic hepatitis C: the role of serum aspartate transaminase in the evaluation of disease progression. European journal of gastroenterology & hepatology. 2004;16(9):891-6.

Saleem N, Mubarik A, Qureshi A, Siddiq M, Ahmad M, Afzal S, et al. Is there a correlation between degree of viremia and liver histology in chronic hepatitis C? Liver. 2004;25:2.

Wu C-K, Chang K-C, Tseng P-L, Lu S-N, Chen C-H, Wang J-H, et al. Comparison of Therapeutic Response and Clinical Outcome between HCV Patients with Normal and Abnormal Alanine Transaminase Levels. PloS one. 2016;11(3):e0142378.

Dor-Mohammadi T, Daryani NE, Bashashati M, Hashtrudi A-A, Haghpanah B, Sayyah A-R, et al. Relationship between serum alanine aminotransferase levels and liver histology in chronic hepatitis C-infected patients. Indian J Gastroenterol. 2005;24(2):49-51.

Mathurin P, Moussalli J, Cadranel JF, Thibault V, Charlotte F, Dumouchel P, et al. Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity. Hepatology. 1998;27(3):868-72.

Lee YS, Yoon SK, Chung ES, Bae SH, Choi JY, Han JY, et al. The relationship of histologic activity to serum ALT, HCV genotype and HCV RNA titers in chronic hepatitis C. J Korean medical science. 2001;16(5):585-91.

Sadasivam K, Chinnasami B, Ravi K, Saravanan A, Kalyanipraba P. LIVER ENZYMES IN OBSTRUCTIVE SLEEP APNOEA SYNDROME. Asian Journal of Pharmaceutical and Clinical Research. 2015;8(4).

Shiffman ML, Diago M, Tran A, Pockros P, Reindollar R, Prati D, et al. Chronic hepatitis C in patients with persistently normal alanine transaminase levels. Clinical Gastroenterology and Hepatology. 2006;4(5):645-52.

Kyrlagkitsis I, Portmann B, Smith H, O'Grady J, Cramp ME. Liver histology and progression of fibrosis in individuals with chronic hepatitis C and persistently normal ALT. American j of gastroenterology. 2003;98(7):1588-93.

Association WM. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. Jama. 2013;310(20):2191.

Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J hepatology. 1995;22(6):696-9.

Anastasiou J, Alisa A, Virtue S, Portmann B, Murray-Lyon I, Williams R. Noninvasive markers of fibrosis and inflammation in clinical practice: prospective comparison with liver biopsy. European journal of gastroenterology & hepatology. 2010;22(4):474-80.

Dayem WAAE, Emam M, Shaheen NE, Emara MH, Darweish EM, Abdelwahab NA. Can combinations of non-invasive parameters replace liver biopsy in the diagnosis of hepatic fibrosis in egyptian patients with chronic hepatitis C. British Microbiology Research J. 2013;3(3):259.

Pradat P, Alberti A, Poynard T, Esteban JI, Weiland O, Marcellin P, et al. Predictive value of ALT levels for histologic findings in chronic hepatitis C: a European collaborative study. Hepatology. 2002;36(4):973-7.

Al-Khurri LE, Al-Khafaji KR, Al-Salihi SA, Alwaysi SA, Al-Akayshi RJ. Serum HCV-RNA levels in patients with chronic hepatitis C: Correlation with histological features. Arab J Gastroenterology. 2009;10(1):10-3.

Shahid M, Idrees M, Nasir B, Raja AJ, Raza SM, Amin I, et al. Correlation of biochemical markers and HCV RNA titers with fibrosis stages and grades in chronic HCV-3a patients. European journal of gastroenterology & hepatology. 2014;26(7):788-94.

Puoti C. Antiviral treatment of Hepatitis C Virus Carriers with normal ALT levels: actual utility or unnecessary expense? BJMP. 2011;4(3):4.

Hassan M, Mustapha N, Zawawi F, Earnest B, Voralu K, Pani S. A comparison of genotype and markers of disease severity of chronic hepatitis C in patients with and without end-stage renal disease. Singapore medical journal. 2011;52(2):86-9.

Russo MW, Brown Jr RS. Should patients with chronic hepatitis c who have normal alt levels be treated? Current gastroenterology reports. 2001;3(1):49-53.

Calabrese F, Pontisso P, Pettenazzo E, Benvegnù L, Vario A, Chemello L, et al. Liver cell apoptosis in chronic hepatitis C correlates with histological but not biochemical activity or serum HCV‐RNA levels. Hepatology. 2000;31(5):1153-9.

Hui C-K, Belaye T, Montegrande K, Wright TL. A comparison in the progression of liver fibrosis in chronic hepatitis C between persistently normal and elevated transaminase. J hepatology. 2003;38(4):511-7.

Zapata R. Clinical approach to the patient with chronic hepatitis C infection and normal aminotransferases. Ann Hepatol. 2010;9(Suppl 1):S72-9.

Kumada T, Toyoda H, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, et al. Incidence of hepatocellular carcinoma in hepatitis C carriers with normal alanine aminotransferase levels. Journal of hepatology. 2009;50(4):729-35.

Puoti C, Castellacci R, Montagnese F, Zaltron S, Stornaiuolo G, Bergami N, et al. Histological and virological features and follow-up of hepatitis C virus carriers with normal aminotransferase levels: the Italian prospective study of the asymptomatic C carriers (ISACC). J hepatology. 2002;37(1):117-23.

Lee LP, Dai CY, Chuang WL, Chang WY, Hou NJ, Hsieh MY, et al. Comparison of liver histopathology between chronic hepatitis C patients and chronic hepatitis B and C‐coinfected patients. Journal of gastroenterology and hepatology. 2007;22(4):515-7.

Alberti A. Towards more individualised management of hepatitis C virus patients with initially or persistently normal alanineaminotransferase levels. Journal of hepatology. 2005;42(2):266-74.

Moreno-Otero R, Trapero-Marugan M, Mendoza J. Liver fibrosis assessment by transient elastography in hepatitis C patients with normal alanine aminotransferase. Gut. 2006;55(7):1055-6.

Butt AA, Yan P, Re VL, Rimland D, Goetz MB, Leaf D, et al. Liver fibrosis progression in hepatitis C virus infection after seroconversion. JAMA internal medicine. 2015;175(2):178-85.